The Bad Place11h ago

CounterPunch.org | Drug Ads Are Deceptive and Deadly by Brandon Novick

AI generated summary, Read the full article for complete information.

The piece argues that direct‑to‑consumer prescription‑drug advertising in the United States is both misleading and hazardous, as companies spend billions on emotional marketing that omits crucial risk information while exaggerating benefits; this practice drives Americans to pay far more for less effective, pricier drugs, contributes to serious health harms—including deaths linked to misleading ads for products like Vioxx—and undermines public health. Because only the U.S. and New Zealand permit such ads, the author urges Congress to curb deceptive marketing by requiring clear, prominent disclosure of all risks, imposing hefty fines, and eliminating liability shields, thereby making false advertising unprofitable and encouraging the development and promotion of genuinely safe, effective treatments.

Read more: https://www.counterpunch.org/2026/05/18/drug-ads-are-deceptive-and-deadly/

#Merck #Humira #Ozempic #Vioxx #FirstAmendment

Yonhap Infomax NewsApr 14, 2025
Celltrion's Yuflyma gains FDA approval for interchangeability with Humira, boosting its competitive edge in the lucrative U.S. autoimmune disease treatment market
#YonhapInfomax #Celltrion #Yuflyma #Humira #Interchangeability #FDAApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=58524
Celltrion - 'Yuflyma Achieves Interchangeable Status with Humira in U.S.'

Celltrion's Yuflyma gains FDA approval for interchangeability with Humira, boosting its competitive edge in the lucrative U.S. autoimmune disease treatment market

Yonhap Infomax
tutorialseriJan 30, 2025
How to Self Inject a Humira Pen #howto #diy #Humira
ThirdTier AmyOct 4, 2024

#goodnewsfriday Humans are still amazing. In this week's selection of articles, we learn about ancient food finds and a whale. And good news for California Humira takers.

Ancient cheese discovery
https://www.atlasobscura.com/articles/mummy-cheese-discovery

The world's oldest bread wasn't baked. https://www.aa.com.tr/en/culture/8-600-year-old-bread-found-in-turkiyes-ancient-proto-city-catalhoyuk/3156001

A grey #whale has been sighted in the Atlantic Ocean for the first time in 200 years. https://www.smithsonianmag.com/smart-news/a-rare-gray-whale-believed-extinct-in-the-atlantic-for-200-years-has-been-spotted-off-new-england-180983911/

Blue Shield of California has made #Humira a free drug. There's a welcome trend in making common drugs free for insurers of prescriptions from many companies. https://www.linkedin.com/news/story/blue-shield-makes-popular-drug-free-6181036/

Enjoy the weekend! And be safe. #Floods are dangerous things. Water always wins.

This Mummy Cheese Is Full of Ancient Secrets

The world's oldest known cheese holds the key to kefir's mysterious origins.

Atlas Obscura
cafepharmaJul 18, 2024
Despite layoff announcements, Novartis beats Q2 expectations   — GoodRx teams with Boehringer on Humira biosimilar— Medtech firms have cut more than 14,000 jobs in the past 18 months —http://bit.ly/w28kSd #novartis #earnings #layoffs #humira #biosimilar #goodrx #abbvie #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaJun 7, 2024
AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—http://bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaApr 16, 2024
J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales—Humira biosimilar scripts take off—Intra-Cellular launches 26% to record high, breaking out after depression drug scores big--http://bit.ly/w28kSd #earnings #jnj #abbvie #humira #biosimilars #depression #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaApr 9, 2024
5 successful phase III oncology trials in Q1—FDA gives nod to BrainStorm for ALS trial after Phase III flop—AbbVie’s Humira loses only 4% of market share to biosimilars--http://bit.ly/w28kSd #clinicaltrials #oncology #fda #als #abbvie #humira #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaApr 5, 2024
J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--http://bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
healthnotesMar 18, 2024

An amazing story from STAT's Bob Herman showing how #PBMs protect their profits even when cheaper #generics or #biosimilars reach the market.

As #Humira biosimilars take over the market, $CVS has created a new ploy: the drug ‘rebate credit’ #rebatecredit
https://www.statnews.com/2024/03/18/humira-pbms-cvs-caremark-rebate-credits/

As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

As Humira biosimilars have taken over the market, CVS Caremark has created a new ploy to make money: the drug "rebate credit."

STAT